At the UPMC Liver Steatosis Metabolic Wellness Program, our team closely monitors clinical trials.
The team includes:
If you're thinking about taking part in a clinical trial, it's important to:
People with biopsy-proven noncirrhotic NASH.
Study randomized investigational oral drug vs. placebo and protocol testing at no cost to participants.
Participants randomized to chance of study drug or placebo for 18 months. Then may continue with active study drug for all participants (no placebo after 18 months).
Up to six years.
Actively enrolling.
Amy Roundtree Schmotzer, RN, at 412-802-8567 or schmotzerar@upmc.edu.
People with biopsy-proven noncirrhotic NASH.
Study randomized investigational drug vs. placebo and protocol testing at no cost to participants.
Study participants taking medication for 24 weeks, then see them four weeks later for safety evaluation.
Closed to accrual. Participants on follow up.
Amy Roundtree Schmotzer, RN, at 412-802-8567 or schmotzerar@upmc.edu.
For more information about clinical trials, please contact Amy Roundtree Schmotzer, RN, at 412-802-8567 or schmotzerar@upmc.edu.
To make an appointment for care, contact the UPMC Liver Steatosis and Metabolic Wellness Program at 412-647-1170.
Your health information, right at your fingertips. Select MyUPMC to access your UPMC health information. For patients of UPMC-affiliated doctors in Central Pa, select UPMC Central Pa Portal. Patients of UPMC Cole should select the UPMC Cole Connect Patient Portal.
The portal for all UPMC patients EXCEPT those in Central Pa.
The portal for UPMC patients in Central Pa.
The portal for UPMC Cole patients receiving inpatient care.
